Search for: All records

The binding motifs of clusters of Al+ and Al2+ with ethane, Alx+(C2H6)n (x = 1, 2; n = 1–3), are determined using vibrational photodissociation spectroscopy in the C–H stretching region (2550–3100 cm−1) in conjunction with spectra calculated using density functional theory. The relative energies of candidate structures are determined with the B3LYP-D3 and ωB97X-D density functionals and the 6–311++G(d,p) basis set. Local mode Hamiltonian calculations are better able to reproduce the spectra than scaled harmonic calculations, due to contributions from bending overtones and combination bands. Vibrational photodissociation spectra show a red shift in the stretching frequencies of C–H bonds that are proximate to the cation. This red shift decreases as the number of ethanes increases. For Al+(C2H6)n (n = 1–3), side-on (T-shaped) binding of the metal is preferred to end-on binding, and subsequent ligands bind on the same side of the cation. Similarly, for Al2+(C2H6)n (n = 1–3), T-shaped configurations in which the C–C and Al–Al bonds are approximately perpendicular and the ethane binds side-on to the Al2+ are preferred. In Al2+(C2H6)n (n = 1–3) complexes, intense bands are observed, which are due to overtones and combinations of symmetric deformations in Fermi resonance with the red-shifted C–H stretches. 

AbstractThe pharmaceutical industry employs various strategies to improve cell productivity. These strategies include process intensification, culture media improvement, clonal selection, media supplementation and genetic engineering of cells. However, improved cell productivity has inherent risk of impacting product quality attributes (PQA). PQAs may affect the products’ efficacy via stability, bioavailability, or in vivo bioactivity. Variations in manufacturing process may introduce heterogeneity in the products by altering the type and extent of N-glycosylation, which is a PQA of therapeutic proteins. We investigated the effect of different cell densities representing increasing process intensification in a perfusion cell culture on the production of an IgG1-κ monoclonal antibody from a CHO-K1 cell line. This antibody is glycosylated both on light chain and heavy chain. Our results showed that the contents of glycosylation of IgG1-κ mAb increased in G0F and fucosylated type glycans as a group, whereas sialylated type glycans decreased, for the mAb whole protein. Overall, significant differences were observed in amounts of G0F, G1F, G0, G2FS1, and G2FS2 type glycans across all process intensification levels. G2FS2 and G2 type N-glycans were predominantly quantifiable from light chain rather than heavy chain. It may be concluded that there is a potential impact to product quality attributes of therapeutic proteins during process intensification via perfusion cell culture that needs to be assessed. Since during perfusion cell culture the product is collected throughout the duration of the process, lot allocation needs careful attention to process parameters, as PQAs are affected by the critical process parameters (CPPs). Key points• Molecular integrity may suffer with increasing process intensity.• Galactosylated and sialylated N-glycans may decrease.• Perfusion culture appears to maintain protein charge structure.